The Burkina Faso government has unveiled a groundbreaking initiative to slash the cost of essential generic drugs and medical supplies, marking one of the most significant healthcare price reductions in recent history. This strategic move aims to enhance equitable access to medical treatment across the nation.
The announcement follows a decisive Council of Ministers meeting held on February 12, 2026, where authorities approved sweeping price reductions for drugs distributed by the Central Purchasing Agency for Essential Generic Medicines (CAMEG). The new pricing structure will take effect on March 1, 2026.
unprecedented price cuts across key categories
According to Dr. Robert Lucien Jean-Claude Kargougou, Minister of Health, the reductions span multiple product categories:
- Tablets and capsules: Up to 67.27% price drop
- Injectable medications: 53.47% reduction in cost
- Syrups and suspensions: 20% price cut
- Medical consumables: Maximum 72.73% decrease
financial backing to drive accessibility
To ensure the success of this reform, the government has allocated a substantial budget of 3 billion FCFA. This financial commitment underscores the nation’s dedication to alleviating the financial burden of healthcare on households while promoting fairness in medical service delivery.
These sweeping changes come just months after a similar initiative in May 2025, which generated budgetary savings of nearly 5 billion FCFA. The cumulative impact of these reforms reflects the administration’s unwavering commitment to providing high-quality, affordable healthcare to all citizens.
a step toward health equity
By making essential medications more affordable, Burkina Faso is taking a bold step toward closing the healthcare access gap. The move is expected to particularly benefit low-income families, enabling them to prioritize health without financial strain. This landmark decision sets a new standard for public health policy in the West African region.
